Real-World Data on First-line Treatment of Hormone Receptor-positive, HER2-negative, Metastatic Breast Cancer in Brazil
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Sponsor: Latin American Cooperative Oncology Group
Collaborators: Brazilian Breast Cancer Study Group (GBECAM)